Market Research

South Korea Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis an

Best Price Guarantee Length Publisher Published Date SKU
from $2,490 73 Pages Allied Market Research June, 2023 ALMR18790699
Best Price Guarantee
Price from $2,490
Length 73 Pages
Publisher Allied Market Research
Published Date June, 2023
SKU ALMR18790699

South Korea Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032


The South Korea point-of-care glucose testing market is expected to witness significant growth during the forecast period. Factors such as increase in prevalence of diabetes in South Korea type 2 diabetes, the demand for point-of-care glucose testing solutions has surged. Furthermore, technological advancements have rendered devices more precise & user-friendly, enhancing their adoption among a tech-savvy populace. However, stringent regulations are expected to hinder the market growth. In addition, high implementation costs are expected to restrict the development of the market. Furthermore, economic downturns and healthcare budget constraints, which can significantly affect the purchasing power of healthcare institutions & individuals, thereby affecting the overall demand for glucose testing products. On the other hand, expanding role of point-of-care glucose testing in home healthcare settings is projected to benefit the market growth. In addition, increase in aging population and rise in preference for at-home monitoring are anticipated to create potential opportunities for the market expansion in the coming years.

The future of the South Korea point-of-care glucose testing market is expected to witness several trends in the coming years. The development of compact, connected, and user-friendly devices is expected to gain high traction in the future. In addition, integration of data management and telehealth services with glucose testing products is expected to intensify the growth of the market. The potential for remote monitoring and telemedicine in diabetes care is vast, particularly in South Korea, with its well-developed IT infrastructure. Leveraging this opportunity will not only improve patient care but open new revenue streams for manufacturers. Companies are focused on new product development. In addition, they are heavily investing in R&D activities to introduce innovations and explore new materials & technologies to enhance product performance.

Moreover, they are adopting price strategies to enhance the production of their product and boost the value & affordability of the products. The Porter's five forces state that the threat of new entrants is a mysterious force that constantly looms. The barriers to entry in this market are not always clear, as innovation and adaptation play significant roles. While the allure of a growing market beckons new players, the complexities of regulation and consumer perceptions can act as formidable barriers. The bargaining power of suppliers, adds a layer of complexity. The suppliers in this market, from manufacturers of glucose monitoring devices to healthcare institutions, often hold the keys to the kingdom. The intricate web of supply chains and agreements can influence market dynamics in unforeseen ways. The bargaining power of buyers, is a force that can sway the market in unpredictable directions. The enigmatic preferences and expectations of buyers, whether they are healthcare providers or patients influence pricing, innovation, and the overall market scenario.

The threat of substitute products adds intrigue to the equation. In a market that is constantly evolving, the definition of substitutes is not always clear. As integrated glucose monitoring systems and alternative healthcare solutions emerge, the boundaries of substitution become blurred. The battle for dominance, fueled by innovation, compliance, and pricing strategies, creates a dynamic and ever-changing landscape. The competitive rivalry is the epicenter of the South Korea point-of-care glucose testing market's enigmatic character. A SWOT analysis provides a comprehensive view of the South Korea Point-of-Care Glucose Testing Market's strengths, weaknesses, opportunities, and threats. The strengths of this market lie in its technological advancements, diverse product range, and the growing prevalence of diabetes, especially type-2 diabetes. These strengths provide a solid foundation for market growth, but they create challenges, such as high costs and regulatory complexities. The weaknesses of the market include the inherent cost associated with advanced glucose monitoring devices and the intricate web of regulations that define the landscape. The opportunities are abundant. The rise of home healthcare settings, the evolution of integrated monitoring systems, and the ever-present quest for innovation all offer avenues for growth. The threats posed by competitive rivalry, the threat of new entrants, and the shifting landscape of substitute products and services.

Key players operating in the South Korea point-of-care glucose testing market include Abbott, Johnson & Johnson, Roche Diagnostics, Siemens Healthineers, Baxter, Alere, Medtronic, Nova Biomedical, Samsung Medical Devices, and Acon Laboratories.

Key Benefits For Stakeholders

Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.

Analyze the key strategies adopted by major market players in South Korea point-of-care glucose testing market.

Assess and rank the top factors that are expected to affect the growth of South Korea point-of-care glucose testing market.

Top Player positioning provides a clear understanding of the present position of market players.

Detailed analysis of the South Korea point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.

Identify key investment pockets for various offerings in the market.
Product Benchmarking / Product specification and applications
Upcoming/New Entrant by Regions
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others

By Application

Type-1 Diabetes
Type-2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

Key Market Players

Abbott
Johnson & Johnson
Roche Diagnostics
Siemens Healthineers
Baxter
Alere
Medtronic
Nova Biomedical
Samsung Medical Devices
Acon Laboratories

Please Note: It will take 7-10 business days to complete the report upon order confirmation. 


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Abbott
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Johnson & Johnson
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Roche Diagnostics
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthineers
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Baxter
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Alere
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Medtronic
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Nova Biomedical
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Samsung Medical Devices
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Acon Laboratories
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT: KEY EXECUTIVES
TABLE 05. ABBOTT: COMPANY SNAPSHOT
TABLE 06. ABBOTT: OPERATING SEGMENTS
TABLE 07. ABBOTT: PRODUCT PORTFOLIO
TABLE 08. ABBOTT: KEY STRATERGIES
TABLE 09. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 10. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 11. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 12. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 13. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 14. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 15. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 16. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 17. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 18. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 24. BAXTER: KEY EXECUTIVES
TABLE 25. BAXTER: COMPANY SNAPSHOT
TABLE 26. BAXTER: OPERATING SEGMENTS
TABLE 27. BAXTER: PRODUCT PORTFOLIO
TABLE 28. BAXTER: KEY STRATERGIES
TABLE 29. ALERE: KEY EXECUTIVES
TABLE 30. ALERE: COMPANY SNAPSHOT
TABLE 31. ALERE: OPERATING SEGMENTS
TABLE 32. ALERE: PRODUCT PORTFOLIO
TABLE 33. ALERE: KEY STRATERGIES
TABLE 34. MEDTRONIC: KEY EXECUTIVES
TABLE 35. MEDTRONIC: COMPANY SNAPSHOT
TABLE 36. MEDTRONIC: OPERATING SEGMENTS
TABLE 37. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 38. MEDTRONIC: KEY STRATERGIES
TABLE 39. NOVA BIOMEDICAL: KEY EXECUTIVES
TABLE 40. NOVA BIOMEDICAL: COMPANY SNAPSHOT
TABLE 41. NOVA BIOMEDICAL: OPERATING SEGMENTS
TABLE 42. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 43. NOVA BIOMEDICAL: KEY STRATERGIES
TABLE 44. SAMSUNG MEDICAL DEVICES: KEY EXECUTIVES
TABLE 45. SAMSUNG MEDICAL DEVICES: COMPANY SNAPSHOT
TABLE 46. SAMSUNG MEDICAL DEVICES: OPERATING SEGMENTS
TABLE 47. SAMSUNG MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 48. SAMSUNG MEDICAL DEVICES: KEY STRATERGIES
TABLE 49. ACON LABORATORIES: KEY EXECUTIVES
TABLE 50. ACON LABORATORIES: COMPANY SNAPSHOT
TABLE 51. ACON LABORATORIES: OPERATING SEGMENTS
TABLE 52. ACON LABORATORIES: PRODUCT PORTFOLIO
TABLE 53. ACON LABORATORIES: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT: NET SALES, 2020-2022* ($MILLION)
FIGURE 21. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. JOHNSON & JOHNSON: NET SALES, 2020-2022* ($MILLION)
FIGURE 24. JOHNSON & JOHNSON: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. JOHNSON & JOHNSON: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. ROCHE DIAGNOSTICS: NET SALES, 2020-2022* ($MILLION)
FIGURE 27. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022* ($MILLION)
FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. BAXTER: NET SALES, 2020-2022* ($MILLION)
FIGURE 33. BAXTER: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. BAXTER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. ALERE: NET SALES, 2020-2022* ($MILLION)
FIGURE 36. ALERE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. ALERE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. MEDTRONIC: NET SALES, 2020-2022* ($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. NOVA BIOMEDICAL: NET SALES, 2020-2022* ($MILLION)
FIGURE 42. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. NOVA BIOMEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. SAMSUNG MEDICAL DEVICES: NET SALES, 2020-2022* ($MILLION)
FIGURE 45. SAMSUNG MEDICAL DEVICES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. SAMSUNG MEDICAL DEVICES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. ACON LABORATORIES: NET SALES, 2020-2022* ($MILLION)
FIGURE 48. ACON LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. ACON LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

$3,255
$2,490
$4,065
$5,055

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings